Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

Sarah Gilbert, COI Principal Investigator, receives Royal Society of Chemistry Honorary Fellowship

Professor Dame Sarah Gilbert honoured for outstanding contributions to global vaccine research and public health impact.

COI Spatial Profiling Hub receives formal accreditation as a Bruker Academic Partner

We’re pleased to announce that the CAMS Oxford Institute Spatial and Gene Profiling Hub has been formally recognized by Bruker Spatial Biology for its generation of high-quality spatial transcriptomic and proteomic data across its nCounter® and GeoMx® Digital Spatial Profiler platforms.

Matthew Bottomley: The Latest Winner in CRUK’s ‘Research is Beautiful’ Campaign

Research is Beautiful campaign continues to inspire with some fantastic images. Congratulations to Dr Matthew Bottomley of the CAMS Oxford Institute, his image shoes a cutaneous squamous cell carcinoma infiltrating into the dermis.

Researchers develop new method to identify fake Covid-19 vaccines

Researchers at the University of Oxford and their collaborators, including the Serum Institute of India, have developed an innovative method to identify falsified vaccines without opening the vaccine vial.

New funding to create a Lymphoid Organoid and Explant Hub received from NC3Rs

Dr Pablo F. Céspedes, CAMS Oxford Institute Career Development Fellow, has received funding from NC3Rs to establish a lymphoid organoid and explant hub at the University of Oxford.

Adán Pinto-Fernández wins a 2024 OCION Pump Prime Award

Career Development Fellow Adán Pinto-Fernández has won the CRUK-Centre for his project titled Targeting ISGylation to Boost Cancer Antigenicity: A Novel Approach for Cancer Immunotherapy

University of Oxford unveils new vaccine development partnership

Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.

Novel antibody platform tackles viral mutations

Scientists in the Nuffield Department of Medicine and the Icahn School of Medicine at Mount Sinai have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade existing vaccines and therapies.

T-cell aerosol immunisation as path to universal influenza vaccine

In a new study, published in NPJ Vaccines, researchers from the Pandemic Sciences Institute and The Pirbright Institute have generated new evidence supporting the development of a universal influenza vaccine.

Adán Pinto-Fernández Secures Prestigious 2-Year Grant from Boehringer Ingelheim

CAMS Oxford Institute Group Leader and Career Development Fellow, Adán Pinto-Fernández, has been awarded a highly competitive 2-year project grant by Boehringer Ingelheim through their Open Innovation Portal initiative, opnMe.

ORTU awarded £2.8m to study treatment for pleural infection

The Oxford Respiratory Trials Unit (ORTU) at the Nuffield Department of Medicine has been awarded a £2.8 million grant from the National Institute for Health and Care Research Health Technology Assessment (NIHR HTA) to conduct the MIST4 study.

Peijun Zhang elected to European Molecular Biology Organization membership

120 scientists from across Europe and beyond have been elected to the European Molecular Biology Organization (EMBO) membership, an honour that celebrates research excellence and outstanding achievements in the life sciences, including Dr Peijun Zhang from the Nuffield Department of Medicine.

Sepsis patients could get the right treatment faster based on their genes

Sepsis patients could be treated based on their immune system’s response to infection, not their symptoms. New research uncovers how different people respond to sepsis based on their genetic makeup, which could help identify who would benefit from certain treatments and lead to the development of targeted therapies.

Novel data method sheds light on hidden patterns of kidney inflammation

Globally kidney disease is forecast to be the 5th leading cause of death by 2040, and in the UK more than 3 million people are living with the most severe stages of chronic kidney disease. Chronic kidney disease is often due to autoimmune damage to the filtration units of the kidney, known as the glomeruli, which can occur in lupus, a disease which disproportionally affects women and people of non-white ethnicities, groups often underrepresented in research. Treatment options are limited, can have life threatening side-effects and often don’t slow the disease, which can then progress to end stage, requiring dialysis or a kidney transplant.

Three CAMS Oxford Institute Principal Investigators elected to the Fellowship of the Academy of Medical Sciences

Professor Teresa Lambe OBE, Professor Julian Knight & Professor Jane McKeating have been elected as Fellows of the Academy of Medical Sciences, one of the most prestigious awards in the field.

Nature Nanotechnology study introduces new and improved version of all-in-one coronavirus vaccine

CAMS Oxford Institute researchers publish an improved version of a novel all-in-one vaccine against coronavirus threats in Nature Nanotechnology.

Ono Pharmaceutical Co collaborates with CAMS Oxford Institute & Centre for Medicines Discovery for translational research

The Centre for Medicines Discovery (CMD) and CAMS Oxford Institute (COI) at NDM, has recently partnered with Ono Pharmaceutical Co (Ono) to validate and develop novel targets in a bid to discover innovative medicines.

NLRP3 Inflammasome “DUBbed” by UCH-L1, affecting IL-1β production in macrophages and microglia

A Cell Reports study led by Prof. Benedikt Kessler provides an intricate time-resolved molecular map of different phases of NLRP3 inflammasome activation and unveils ubiquitin C-terminal hydrolase 1 (UCH-L1) as a modulator of NLRP3 inflammasome assembly and IL-1β production.

CAMS Oxford Institute Symposium held in Oxford

The annual CAMS Oxford Institute Symposium was held on Monday 15th April 2024 in the Richard Doll Building on Old Road Campus for a full day of scientific talks, poster presentations & networking.

Novel pairing of integrins improves action of T cells on cancer cells to control tumour growth

New research published in Nature Immunology showcases the collaborative efforts of CAMS Oxford Institute researchers to describe a novel pairing of integrins which could improve T cell control of cancer.

Load More